Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Strategies for the Treatment of Parkinson’s Disease: Beyond Dopamine
Authors
Keywords
-
Journal
Frontiers in Aging Neuroscience
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-01-31
DOI
10.3389/fnagi.2020.00004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- α-Synuclein and astrocytes: tracing the pathways from homeostasis to neurodegeneration in Lewy body disease
- (2019) Zachary A. Sorrentino et al. ACTA NEUROPATHOLOGICA
- Non‐viral nucleic acid delivery to the central nervous system and brain tumors
- (2019) Shanshan Wang et al. JOURNAL OF GENE MEDICINE
- CLINICAL TRIAL HIGHLIGHTS: 1. GENE THERAPY FOR PARKINSON’S, 2. PHASE 3 STUDY IN FOCUS - INTEC PHARMA’S ACCORDION PILL, 3. CLINICAL TRIALS RESOURCES
- (2019) Kevin McFarthing et al. Journal of Parkinsons Disease
- Clinical translation of gene medicine
- (2019) Fazhan Wang et al. JOURNAL OF GENE MEDICINE
- Contribution of cholinergic interneurons to striatal pathophysiology in Parkinson's disease
- (2019) Samira Ztaou et al. NEUROCHEMISTRY INTERNATIONAL
- Generation of a caged lentiviral vector through an unnatural amino acid for photo-switchable transduction
- (2019) Yan Wang et al. NUCLEIC ACIDS RESEARCH
- Human gene therapy approaches for the treatment of Parkinson's disease: An overview of current and completed clinical trials
- (2019) Frederick L. Hitti et al. PARKINSONISM & RELATED DISORDERS
- Development of hRad51–Cas9 nickase fusions that mediate HDR without double-stranded breaks
- (2019) Holly A. Rees et al. Nature Communications
- Surveillance and transportation of mitochondria in neurons
- (2019) Roeland Vanhauwaert et al. CURRENT OPINION IN NEUROBIOLOGY
- Targeting microglia with lentivirus and AAV: Recent advances and remaining challenges
- (2019) Margaret E. Maes et al. NEUROSCIENCE LETTERS
- Developing a Versatile Shotgun Cloning Strategy for Single-Vector-Based Multiplex Expression of Short Interfering RNAs (siRNAs) in Mammalian Cells
- (2019) Xi Wang et al. ACS Synthetic Biology
- Search-and-replace genome editing without double-strand breaks or donor DNA
- (2019) Andrew V. Anzalone et al. NATURE
- CRISPR System: A High-throughput Toolbox for Research and Treatment of Parkinson’s Disease
- (2019) Fatemeh Safari et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Integration of the human exposome with the human genome to advance medicine
- (2018) R. Barouki et al. BIOCHIMIE
- Candidate biomarkers for Parkinson's disease
- (2018) Ali Khodadadian et al. BIOMEDICINE & PHARMACOTHERAPY
- Long-term Outcome of Adenosine A2A Receptor Antagonist on Lower Urinary Tract Symptoms in Male Parkinson Disease Patients
- (2018) Takeya Kitta et al. CLINICAL NEUROPHARMACOLOGY
- Delivering CRISPR: a review of the challenges and approaches
- (2018) Christopher A. Lino et al. DRUG DELIVERY
- Primary tissue for cellular brain repair in Parkinson's disease: Promise, problems and the potential of biomaterials
- (2018) Niamh Moriarty et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Intranasal Cotinine Plus Krill Oil Facilitates Fear Extinction, Decreases Depressive-Like Behavior, and Increases Hippocampal Calcineurin A Levels in Mice
- (2018) Nathalie Alvarez-Ricartes et al. MOLECULAR NEUROBIOLOGY
- (E)-Nicotinaldehyde O-Cinnamyloxime, a Nicotine Analog, Attenuates Neuronal Cells Death Against Rotenone-Induced Neurotoxicity
- (2018) Juan Camilo Jurado-Coronel et al. MOLECULAR NEUROBIOLOGY
- International Parkinson and movement disorder society evidence-based medicine review: Update on treatments for the motor symptoms of Parkinson's disease
- (2018) Susan H. Fox et al. MOVEMENT DISORDERS
- p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells
- (2018) Robert J. Ihry et al. NATURE MEDICINE
- Alpha-synuclein: Pathology, mitochondrial dysfunction and neuroinflammation in Parkinson’s disease
- (2018) Emily M. Rocha et al. NEUROBIOLOGY OF DISEASE
- Ventral midbrain astrocytes display unique physiological features and sensitivity to dopamine D2 receptor signaling
- (2018) Wendy Xin et al. NEUROPSYCHOPHARMACOLOGY
- α-Synuclein oligomers induce early axonal dysfunction in human iPSC-based models of synucleinopathies
- (2018) Iryna Prots et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Gene Therapy for Parkinson’s Disease, An Update
- (2018) Tobias M. Axelsen et al. Journal of Parkinsons Disease
- Is There Evidence for a Rostral-Caudal Gradient in Fronto-Striatal Loops and What Role Does Dopamine Play?
- (2018) David A. Vogelsang et al. Frontiers in Neuroscience
- Linking Glycation and Glycosylation With Inflammation and Mitochondrial Dysfunction in Parkinson’s Disease
- (2018) Paula A. Q. Videira et al. Frontiers in Neuroscience
- Emerging and alternative therapies for Parkinson disease: an updated review
- (2018) Atul Kabra et al. CURRENT PHARMACEUTICAL DESIGN
- Cotinine Reduces Amyloid-β Aggregation and Improves Memory in Alzheimer's Disease Mice
- (2018) Valentina Echeverria et al. JOURNAL OF ALZHEIMERS DISEASE
- Gene therapy for neurological disorders: progress and prospects
- (2018) Benjamin E. Deverman et al. NATURE REVIEWS DRUG DISCOVERY
- Expression of α-synuclein is regulated in a neuronal cell type-dependent manner
- (2018) Katsutoshi Taguchi et al. ANATOMICAL SCIENCE INTERNATIONAL
- Nicotine protects against manganese and iron-induced toxicity in SH-SY5Y cells: Implication for Parkinson's disease
- (2018) Bruk Getachew et al. NEUROCHEMISTRY INTERNATIONAL
- Striatal cholinergic interneurons and Parkinson's disease
- (2017) Asami Tanimura et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Stem Cells for Modeling and Therapy of Parkinson's Disease
- (2017) Qingxi Zhang et al. HUMAN GENE THERAPY
- Clinical Gene Therapy for Neurodegenerative Diseases: Past, Present, and Future
- (2017) Françoise Piguet et al. HUMAN GENE THERAPY
- CRISPR-Cas9 Mediated Telomere Removal Leads to Mitochondrial Stress and Protein Aggregation
- (2017) Hyojung Kim et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Management of Parkinson Disease in 2017
- (2017) Michael S. Okun JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- The changing landscape of surgery for Parkinson's Disease
- (2017) Christopher S. Lozano et al. MOVEMENT DISORDERS
- Cognitive decline in Parkinson disease
- (2017) Dag Aarsland et al. Nature Reviews Neurology
- Non-motor features of Parkinson disease
- (2017) Anthony H. V. Schapira et al. NATURE REVIEWS NEUROSCIENCE
- Neural grafting for Parkinson's disease: challenges and prospects
- (2017) ThomasB Stoker et al. Neural Regeneration Research
- Caffeine as symptomatic treatment for Parkinson disease (Café-PD)
- (2017) Ronald B. Postuma et al. NEUROLOGY
- Cotinine improves visual recognition memory and decreases cortical Tau phosphorylation in the Tg6799 mice
- (2017) J. Alex Grizzell et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Dopamine oxidation mediates mitochondrial and lysosomal dysfunction in Parkinson’s disease
- (2017) Lena F. Burbulla et al. SCIENCE
- Cell Biology and Pathophysiology of α-Synuclein
- (2017) Jacqueline Burré et al. Cold Spring Harbor Perspectives in Medicine
- Mesenchymal Stem Cells as a Source of Dopaminergic Neurons: A Potential Cell Based Therapy for Parkinson's Disease
- (2017) Katari Venkatesh et al. Current Stem Cell Research & Therapy
- Replacing Dopamine Neurons in Parkinson’s Disease: How did it happen?
- (2017) Anders Björklund et al. Journal of Parkinsons Disease
- MicroRNAs in Parkinson’s disease
- (2017) Abhishek Singh et al. EXPERIMENTAL BRAIN RESEARCH
- Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations
- (2017) Anthony H. V. Schapira et al. JAMA Neurology
- Synucleins and Gene Expression: Ramblers in a Crowd or Cops Regulating Traffic?
- (2017) Alexei A. Surguchev et al. Frontiers in Molecular Neuroscience
- RNA Interference of Human α-Synuclein in Mouse
- (2017) Young-Cho Kim et al. Frontiers in Neurology
- Imaging biomarkers in Parkinson’s disease and Parkinsonian syndromes: current and emerging concepts
- (2017) Usman Saeed et al. Translational Neurodegeneration
- Worsening of Verbal Fluency After Deep Brain Stimulation in Parkinson's Disease: A Focused Review
- (2017) Andreas Højlund et al. Computational and Structural Biotechnology Journal
- Alpha-Synuclein as a Biomarker for Parkinson's Disease
- (2016) Anzari Atik et al. BRAIN PATHOLOGY
- Repression of the Antioxidant NRF2 Pathway in Premature Aging
- (2016) Nard Kubben et al. CELL
- Induced pluripotent stem cells and Parkinson's disease: modelling and treatment
- (2016) Xiaoyun Xu et al. CELL PROLIFERATION
- Implication of Green Tea as a Possible Therapeutic Approach for Parkinson Disease
- (2016) Juan C. Jurado-Coronel et al. CNS & Neurological Disorders-Drug Targets
- Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson's Disease
- (2016) Juan Camilo Jurado-Coronel et al. CURRENT PHARMACEUTICAL DESIGN
- Molecular basis of reactive oxygen species-induced inactivation of α4β2 nicotinic acetylcholine receptors
- (2016) Junjun Zhao et al. FREE RADICAL BIOLOGY AND MEDICINE
- Mitochondrial dysfunction in Parkinson's disease
- (2016) Anindita Bose et al. JOURNAL OF NEUROCHEMISTRY
- Cognitive impairment in Parkinson's disease and dementia with Lewy bodies
- (2016) Dag Aarsland PARKINSONISM & RELATED DISORDERS
- Are Stem Cell-Based Therapies for Parkinson’s Disease Ready for the Clinic in 2016?
- (2016) Roger A. Barker et al. Journal of Parkinsons Disease
- Time Trends in the Incidence of Parkinson Disease
- (2016) Rodolfo Savica et al. JAMA Neurology
- Improvement of dyskinesias withl-dopa infusion in advanced Parkinson's disease
- (2015) J. Timpka et al. ACTA NEUROLOGICA SCANDINAVICA
- Alpha-synuclein (SNCA) polymorphisms and susceptibility to Parkinson's disease: A meta-analysis
- (2015) Wei Han et al. AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS
- Mitochondrial dysfunction in aging: Much progress but many unresolved questions
- (2015) Brendan A.I. Payne et al. BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS
- Neuroprotective Properties of the Standardized Extract fromCamellia sinensis(Green Tea) and Its Main Bioactive Components, Epicatechin and Epigallocatechin Gallate, in the 6-OHDA Model of Parkinson’s Disease
- (2015) Natália Bitu Pinto et al. Evidence-based Complementary and Alternative Medicine
- Istradefylline is Recommended for Morning Use: A Report of 4 Cases
- (2015) Keita Matsuura et al. INTERNAL MEDICINE
- Mutations in the glucocerebrosidase gene are common in patients with Parkinson's disease from Eastern Canada
- (2015) Fabin Han et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- 1α,25-Dihydroxyvitamin D3Regulates Mitochondrial Oxygen Consumption and Dynamics in Human Skeletal Muscle Cells
- (2015) Zachary C. Ryan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- shRNA targeting α-synuclein prevents neurodegeneration in a Parkinson’s disease model
- (2015) Alevtina D. Zharikov et al. JOURNAL OF CLINICAL INVESTIGATION
- Evidence for limited D1 and D2 receptor coexpression and colocalization within the dorsal striatum of the neonatal mouse
- (2015) Dominik K. Biezonski et al. JOURNAL OF COMPARATIVE NEUROLOGY
- Clinical translation of stem cell transplantation in Parkinson's disease
- (2015) O. Lindvall JOURNAL OF INTERNAL MEDICINE
- Distinct Midbrain and Habenula Pathways Are Involved in Processing Aversive Events in Humans
- (2015) K. Hennigan et al. JOURNAL OF NEUROSCIENCE
- Evidence against dopamine D1/D2 receptor heteromers
- (2015) A L Frederick et al. MOLECULAR PSYCHIATRY
- Striatal cholinergic interneurons and cortico-striatal synaptic plasticity in health and disease
- (2015) Marc Deffains et al. MOVEMENT DISORDERS
- Deep-brain stimulation associates with improved microvascular integrity in the subthalamic nucleus in Parkinson's disease
- (2015) Ilse S. Pienaar et al. NEUROBIOLOGY OF DISEASE
- Regulation of c-fos expression by the dopamine D1-D2 receptor heteromer
- (2015) M.L. Perreault et al. NEUROSCIENCE
- The Parkinson Disease Mitochondrial Hypothesis
- (2015) Sandra Franco-Iborra et al. NEUROSCIENTIST
- Pharmacokinetics of cotinine in rats: A potential therapeutic agent for disorders of cognitive function
- (2015) Pei Li et al. Pharmacological Reports
- Treatment of Parkinson's disease using cell transplantation
- (2015) Olle Lindvall PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson’s disease
- (2015) George E. Barreto et al. Frontiers in Aging Neuroscience
- Dopamine Receptors and Neurodegeneration
- (2015) Claudia Rangel-Barajas et al. Aging and Disease
- Mitochondrial Dysfunction in Parkinson's Disease
- (2015) Hyo Eun Moon et al. Experimental Neurobiology
- Cotinine reduces depressive-like behavior and hippocampal vascular endothelial growth factor downregulation after forced swim stress in mice.
- (2014) J. Alex Grizzell et al. BEHAVIORAL NEUROSCIENCE
- Cotinine reduces depressive-like behavior, working memory deficits, and synaptic loss associated with chronic stress in mice
- (2014) J. Alex Grizzell et al. BEHAVIOURAL BRAIN RESEARCH
- Evaluation of nicotine and cotinine analogs as potential neuroprotective agents for Alzheimer’s disease
- (2014) Jie Gao et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Endometrial stem cell transplantation in MPTP- exposed primates: an alternative cell source for treatment of Parkinson's disease
- (2014) Erin F. Wolff et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Postoperative delirium in Parkinson’s disease patients following deep brain stimulation surgery
- (2014) Jonathan D. Carlson et al. JOURNAL OF CLINICAL NEUROSCIENCE
- The Parkinsonian mimetic, 6-OHDA, impairs axonal transport in dopaminergic axons
- (2014) Xi Lu et al. Molecular Neurodegeneration
- Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr
- (2014) Andrew J. Lees et al. MOVEMENT DISORDERS
- Neurodegenerative disease: Brain windfall
- (2014) Katharine Gammon NATURE
- Direct and indirect pathways of basal ganglia: a critical reappraisal
- (2014) Paolo Calabresi et al. NATURE NEUROSCIENCE
- Implementing personalized cancer care
- (2014) Richard L. Schilsky Nature Reviews Clinical Oncology
- New Insights into the Mechanisms of Action of Cotinine and its Distinctive Effects from Nicotine
- (2014) J. Alex Grizzell et al. NEUROCHEMICAL RESEARCH
- Multisensory Integration in the Mouse Striatum
- (2014) Ramon Reig et al. NEURON
- Striatal Cholinergic Interneurons Drive GABA Release from Dopamine Terminals
- (2014) Alexandra B. Nelson et al. NEURON
- Cotinine halts the advance of Alzheimer's disease-like pathology and associated depressive-like behavior in Tg6799 mice
- (2014) Sagar Patel et al. Frontiers in Aging Neuroscience
- Nicotinic Acetylcholine Receptor Density in Cognitively Intact Subjects at an Early Stage of Parkinson’s Disease
- (2014) Ioannis Ugo Isaias et al. Frontiers in Aging Neuroscience
- Gender differences in quality of life following subthalamic stimulation for Parkinson's disease
- (2013) G.-M. Hariz et al. ACTA NEUROLOGICA SCANDINAVICA
- The Free Radical Theory of Aging Is Dead. Long Live the Damage Theory!
- (2013) Vadim N. Gladyshev ANTIOXIDANTS & REDOX SIGNALING
- ?7 Nicotinic Acetylcholine Receptor Mediated Neuroprotection in Parkinson's Disease
- (2013) Jun Kawamata et al. CURRENT DRUG TARGETS
- Nicotine-encapsulated poly(lactic-co-glycolic) acid nanoparticles improve neuroprotective efficacy against MPTP-induced parkinsonism
- (2013) Manindra Nath Tiwari et al. FREE RADICAL BIOLOGY AND MEDICINE
- Parkinson disease: from pathology to molecular disease mechanisms
- (2013) David T. Dexter et al. FREE RADICAL BIOLOGY AND MEDICINE
- α-Synuclein Oligomers Impair Neuronal Microtubule-Kinesin Interplay
- (2013) Iryna Prots et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson’s disease
- (2013) G Drui et al. MOLECULAR PSYCHIATRY
- Comparison of Fetal Mesencephalic Grafts, AAV-delivered GDNF, and Both Combined in an MPTP-induced Nonhuman Primate Parkinson’s Model
- (2013) D Eugene Redmond et al. MOLECULAR THERAPY
- Parkinson's Disease Gene Therapy: Success by Design Meets Failure by Efficacy
- (2013) Raymond T Bartus et al. MOLECULAR THERAPY
- Dysregulation of glucose metabolism is an early event in sporadic Parkinson's disease
- (2013) Laura Dunn et al. NEUROBIOLOGY OF AGING
- Safety/feasibility of targeting the substantia nigra with AAV2-neurturin in Parkinson patients
- (2013) R. T. Bartus et al. NEUROLOGY
- Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
- (2013) Amaal AlDakheel et al. Neurotherapeutics
- Distribution and compartmental organization of GABAergic medium-sized spiny neurons in the mouse nucleus accumbens
- (2013) Giuseppe Gangarossa et al. Frontiers in Neural Circuits
- Genetics of Parkinson's Disease
- (2013) C. Klein et al. Cold Spring Harbor Perspectives in Medicine
- Dopamine, Reward, and Frontostriatal Circuitry in Impulse Control Disorders in Parkinson's Disease: Insights from Functional Imaging
- (2012) Nicola Ray et al. CLINICAL EEG AND NEUROSCIENCE
- Cotinine: A Potential New Therapeutic Agent against Alzheimer's disease
- (2012) Valentina Echeverria et al. CNS Neuroscience & Therapeutics
- Psychostimulant effect of levodopa: reversing sensitisation is possible
- (2012) Anna Castrioto et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases
- (2012) Rajnish K. Chaturvedi et al. MOLECULAR AND CELLULAR NEUROSCIENCE
- Evolution of Dopamine Receptor Genes of the D1 Class in Vertebrates
- (2012) Kei Yamamoto et al. MOLECULAR BIOLOGY AND EVOLUTION
- Caffeine for treatment of Parkinson disease: A randomized controlled trial
- (2012) R. B. Postuma et al. NEUROLOGY
- Non-Motor Symptoms in Patients with Parkinson’s Disease – Correlations with Inflammatory Cytokines in Serum
- (2012) Daniel Lindqvist et al. PLoS One
- The basal ganglia: motor and cognitive relationships in a clinical neurobehavioral context
- (2012) Gerry Leisman et al. REVIEWS IN THE NEUROSCIENCES
- Striatal microcircuitry and movement disorders
- (2012) Aryn H. Gittis et al. TRENDS IN NEUROSCIENCES
- Cotinine: Beyond that Expected, More than a Biomarker of Tobacco Consumption
- (2012) Valentina Echeverria Moran Frontiers in Pharmacology
- Modulation of Striatal Projection Systems by Dopamine
- (2011) Charles R. Gerfen et al. Annual Review of Neuroscience
- Single-Cell Redox Imaging Demonstrates a Distinctive Response of Dopaminergic Neurons to Oxidative Insults
- (2011) Maxx P. Horowitz et al. ANTIOXIDANTS & REDOX SIGNALING
- Impulse control disorders in Parkinsonʼs disease
- (2011) Valerie Voon et al. CURRENT OPINION IN NEUROLOGY
- Epidemiology and etiology of Parkinson’s disease: a review of the evidence
- (2011) Karin Wirdefeldt et al. EUROPEAN JOURNAL OF EPIDEMIOLOGY
- Stress, depression and Parkinson's disease
- (2011) Ann M. Hemmerle et al. EXPERIMENTAL NEUROLOGY
- Neuroprotection of midbrain dopamine neurons by nicotine is gated by cytoplasmic Ca2+
- (2011) Damien Toulorge et al. FASEB JOURNAL
- α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases
- (2011) Zane S. Martin et al. JOURNAL OF NEUROCHEMISTRY
- AAV2-GAD gene therapy for advanced Parkinson's disease: a double-blind, sham-surgery controlled, randomised trial
- (2011) Peter A LeWitt et al. LANCET NEUROLOGY
- Interventional MRI-guided Putaminal Delivery of AAV2-GDNF for a Planned Clinical Trial in Parkinson's Disease
- (2011) R Mark Richardson et al. MOLECULAR THERAPY
- Etiology and pathogenesis of Parkinson's disease
- (2011) Anthony H. Schapira et al. MOVEMENT DISORDERS
- GABAergic circuits mediate the reinforcement-related signals of striatal cholinergic interneurons
- (2011) Daniel F English et al. NATURE NEUROSCIENCE
- Increased Oxidative Damage and Decreased Antioxidant Function in Aging Human Substantia Nigra Compared to Striatum: Implications for Parkinson’s Disease
- (2011) C. Venkateshappa et al. NEUROCHEMICAL RESEARCH
- 6 2* and 4 2* Nicotinic Acetylcholine Receptors As Drug Targets for Parkinson's Disease
- (2011) M. Quik et al. PHARMACOLOGICAL REVIEWS
- The Evolution of Dopamine Systems in Chordates
- (2011) Kei Yamamoto et al. Frontiers in Neuroanatomy
- Clinical progression in Parkinson disease and the neurobiology of axons
- (2010) Hsiao-Chun Cheng et al. ANNALS OF NEUROLOGY
- The cholinergic system and Parkinson disease
- (2010) Nicolaas I. Bohnen et al. BEHAVIOURAL BRAIN RESEARCH
- Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial
- (2010) William J Marks et al. LANCET NEUROLOGY
- Basal ganglia physiology and deep brain stimulation
- (2010) Andres M. Lozano et al. MOVEMENT DISORDERS
- Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease
- (2010) Elena Moro et al. MOVEMENT DISORDERS
- A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease
- (2010) Barry J. Snow et al. MOVEMENT DISORDERS
- Maladie de Parkinson : de la physiopathologie des troubles psychiques à la maîtrise du traitement dopaminergique
- (2010) S. Thobois et al. REVUE NEUROLOGIQUE
- Nicotine is a Selective Pharmacological Chaperone of Acetylcholine Receptor Number and Stoichiometry. Implications for Drug Discovery
- (2009) Henry A. Lester et al. AAPS Journal
- Reduced α4β2*–Nicotinic Acetylcholine Receptor Binding and Its Relationship to Mild Cognitive and Depressive Symptoms in Parkinson Disease
- (2009) Philipp M. Meyer et al. ARCHIVES OF GENERAL PSYCHIATRY
- Nicotinic Receptor-Mediated Neuroprotection in Neurodegenerative Disease Models
- (2009) Shun Shimohama BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Functional Effects of AAV2-GDNF on the Dopaminergic Nigrostriatal Pathway in Parkinsonian Rhesus Monkeys
- (2009) Jamie L. Eberling et al. HUMAN GENE THERAPY
- Safety Evaluation of AAV2-GDNF Gene Transfer into the Dopaminergic Nigrostriatal Pathway in Aged and Parkinsonian Rhesus Monkeys
- (2009) Xiaomin Su et al. HUMAN GENE THERAPY
- Decrease of Nicotinic Receptors in the Nigrostriatal System in Parkinson's Disease
- (2009) Aurélie Kas et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Neuronal cell replacement in Parkinson’s disease
- (2009) E. Hedlund et al. JOURNAL OF INTERNAL MEDICINE
- Nicotine is neuroprotective when administered before but not after nigrostriatal damage in rats and monkeys
- (2009) Luping Z. Huang et al. JOURNAL OF NEUROCHEMISTRY
- Parkinson's disease
- (2009) Andrew J Lees et al. LANCET
- Effect of Genome Size on AAV Vector Packaging
- (2009) Zhijian Wu et al. MOLECULAR THERAPY
- Neuroinflammation in the living brain of Parkinson's disease
- (2009) Yasuomi Ouchi et al. PARKINSONISM & RELATED DISORDERS
- Striatal Medium-Sized Spiny Neurons: Identification by Nuclear Staining and Study of Neuronal Subpopulations in BAC Transgenic Mice
- (2009) Miriam Matamales et al. PLoS One
- Are adenosine antagonists, such as istradefylline, caffeine, and chocolate, useful in the treatment of Parkinson's disease?
- (2008) Joseph Jankovic ANNALS OF NEUROLOGY
- Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells
- (2008) Kunal Rehani et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Smoking and Parkinson's disease: Does nicotine affect α-synuclein fibrillation?
- (2008) Dong-Pyo Hong et al. BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS
- Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
- (2008) Cecilia Lundberg et al. CURRENT GENE THERAPY
- Mitochondrial Import and Accumulation of α-Synuclein Impair Complex I in Human Dopaminergic Neuronal Cultures and Parkinson Disease Brain
- (2008) Latha Devi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Deep brain stimulation for parkinsonian gait disorders
- (2008) Andres M. Lozano et al. JOURNAL OF NEUROLOGY
- Mesolimbic Functional Magnetic Resonance Imaging Activations during Reward Anticipation Correlate with Reward-Related Ventral Striatal Dopamine Release
- (2008) B. H. Schott et al. JOURNAL OF NEUROSCIENCE
- Cotinine Selectively Activates a Subpopulation of 3/ 6 2 Nicotinic Receptors in Monkey Striatum
- (2008) K. O'Leary et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Continuous and Intermittent Nicotine Treatment Reduces L-3,4-Dihydroxyphenylalanine (L-DOPA)-Induced Dyskinesias in a Rat Model of Parkinson's Disease
- (2008) T. Bordia et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Adeno-Associated Virus Vector Genomes Persist as Episomal Chromatin in Primate Muscle
- (2008) M. Penaud-Budloo et al. JOURNAL OF VIROLOGY
- Levodopa-related motor complications-Phenomenology
- (2008) Susan H. Fox et al. MOVEMENT DISORDERS
- Results from a phase I safety trial of hAADC gene therapy for Parkinson disease
- (2008) J. L. Eberling et al. NEUROLOGY
- Deep brain stimulation for Parkinson’s disease
- (2008) Patricia Limousin et al. Neurotherapeutics
- Cigarette smoke, nicotine and cotinine protect against 6-hydroxydopamine-induced toxicity in SH-SY5Y cells
- (2008) Karen Riveles et al. NEUROTOXICOLOGY
- Smoking and tea consumption delay onset of Parkinson's disease
- (2008) Boris Kandinov et al. PARKINSONISM & RELATED DISORDERS
- Neuroprotection via nAChRs: the role of nAChRs in neurodegenerative disorders such as Alzheimer's and Parkinson's disease
- (2007) Marina et al. Frontiers in Bioscience-Landmark
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now